E-Library

Leveraging Patient Outcomes and Big Data to Personalize Medical Cannabis The Conference Board of Canada, November 5, 2019 Recorded Webinar

Leveraging Patient Outcomes and Big Data to Personalize Medical Cannabis

The Conference Board of Canada, November 5, 2019
Recorded Webinar

1 2 3 4 5	0 reviews

(You must be signed in and entitled to rate this report)

Medical cannabis has been authorized and used in Canada for over two decades. With the recent legalization of recreational cannabis comes reduced stigma around the drug and an opportunity for organizations to more deeply understand and provide employee support for those requiring this therapy. In this 60 minute recorded webinar, Andrew Muroff, CEO of Strainprint Technologies, dispels some of the myths around medical cannabis and walks through some of the most important patient findings that organizations should be aware of to effectively support their employees. Webinar Highlights Andrew walks through Strainprint’s most recent patient, practitioner and industry data to answer the following questions: What are the top five symptoms and conditions that people are using medical cannabis to treat? What are the most effective methods of consumption and product types? What are the most common emotive effects (e.g. grogginess, sleepiness) being felt by medical cannabis users? What does all of this mean for the employer looking to support their employees in need of medical cannabis treatment? About Andrew Muroff Andrew Muroff, Chief Executive Officer, Strainprint Technologies, is a hands-on entrepreneur that has led public and private technology companies since 1995. To Strainprint, he brings deep corporate and financial experience, broad expertise across regulated cannabis markets in Canada and the U.S., and a passion to help people. He is a published legal author with graduate degrees in Business and Law and is a member of the State Bar of Michigan.

Medical cannabis has been authorized and used in Canada for over two decades. With the recent legalization of recreational cannabis comes reduced stigma around the drug and an opportunity for organizations to more deeply understand and provide employee support for those requiring this therapy.

In this 60 minute recorded webinar, Andrew Muroff, CEO of Strainprint Technologies, dispels some of the myths around medical cannabis and walks through some of the most important patient findings that organizations should be aware of to effectively support their employees.

Webinar Highlights

Andrew walks through Strainprint’s most recent patient, practitioner and industry data to answer the following questions:

What are the top five symptoms and conditions that people are using medical cannabis to treat?
What are the most effective methods of consumption and product types?
What are the most common emotive effects (e.g. grogginess, sleepiness) being felt by medical cannabis users?
What does all of this mean for the employer looking to support their employees in need of medical cannabis treatment?

About Andrew Muroff

Photo of Andrew Muroff Andrew Muroff, Chief Executive Officer, Strainprint Technologies, is a hands-on entrepreneur that has led public and private technology companies since 1995. To Strainprint, he brings deep corporate and financial experience, broad expertise across regulated cannabis markets in Canada and the U.S., and a passion to help people. He is a published legal author with graduate degrees in Business and Law and is a member of the State Bar of Michigan.

		Access Webinar
(you will be asked to sign-in)
To see if you are entitled to get this research for free, take a minute and create a free e-Library account. This will let us determine if someone else at your organization has already purchased access to this material.